InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: patientlywaiting post# 271034

Saturday, 08/27/2016 3:53:57 PM

Saturday, August 27, 2016 3:53:57 PM

Post# of 345700

This Friday I sent to PPHM IR this question "Will PPHM file for an extension in regards to the delisting notice of dollar minimum requirement". I did not receive a reply but will post if I receive one.



I would advise to make all requests/questions..etc sent via registered mail to Peregrine and keep all records, since any and all requests now made may be important to any future lawsuits. Remember, Peregrine did tell the SEC that they respond to questions so at this critical time any questions asked and not answered as a shareholder may come into and prove to the SEC that "No, Peregrine Pharmaceuticals does not answer all shareholder questions..."

Golfho, I'm still working on my list and comparing it to others and it will probably be best to send registered letters to multiple parties within Peregrine / SEC / Nasdaq to make sure things move forward.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News